Research into Faster and More Accurate Detection of Melanoma

A breakthrough has been made in the early detection of melanoma, using a compound called fluorinated benzamine. The development could lead to a much faster and more accurate diagnosis of melanoma.

Melanomas can start out as a blemish or mole and often aren’t taken seriously until cancer cells have spread and it’s too late. The fatal disease is difficult to detect as it often grows under the skin before lesions appear suspicious.

This new compound, which was developed by the Center for Molecular Imaging and Therapy in Los Angeles, could save vital time in diagnosing patients. It works by binding to a melanoma tumour and showing up in a Positron Emission Topography scan. It’s specific to melanoma cells and won’t pick up anything else.

When detected at the early stages, melanoma survivability is nearly 98 percent. But when it’s found too late, the chances of survival drop down to as little as 20 percent.

Melanoma affects every skin type and is prevalent in rural areas where people spend a lot of time in the sun. This breakthrough study could target in on the fatal disease and give patients the knowledge that could save their lives.

The research is still in the pre-clinical trials and the next step will be larger clinical studies. It will take several years before researchers can begin testing in humans.


Source: ArkLatex Homepage

Meachum, A. (June 12, 2017) Research to detect melanoma faster and more accurately. ArkLatex

Learn more about skin cancer medicine in primary care at the next Skin Cancer Certificate Courses:

Skin Cancer Certificate Courses in Australia

Leave a Reply

Your email address will not be published. Required fields are marked *